Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women

Climacteric

Volumn 17, Issue 4, 2014, Pages 465-471

  Bruno, A De Souza ^a   Rodrigues, M H ^a,b   Alvares, M C B ^c   Nahas Neto, J ^a   Nahas, E A Petri ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^c Endocrinology Unit   (Brazil)

Author keywords

Insulin Resistance; Menopause; Metabolic Syndrome; Non Alcoholic Fatty Liver Disease

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ABDOMINAL OBESITY; ADULT; AMENORRHEA; ARTICLE; BLOOD PRESSURE; BODY MASS; BRAZIL; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE; BLOOD; COMPLICATION; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK;

BLOOD GLUCOSE; BODY MASS INDEX; BRAZIL; CHOLESTEROL, LDL; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; POSTMENOPAUSE; PREVALENCE; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84904351490     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2014.881353     Document Type: Article

References (30)

1. Kowdley KV, Caldwell S. Nonalcoholic steatohepatitis. A twentyfi rst century epidemic. J Clin Gastroenterol 2006 ; 40: S2-4
2. Clark J M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006 ; 4 : S5-10
3. Suzuki A, Abdemalek F. Nonalcoholic fatty liver disease in women. Women's Health 2009 ; 5 : 1-13
4. Torres D M, Williams C D, Harrison S A. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012 ; 10 : 837-58
5. Loria P, Adinolfi L E, Bellentani S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010 ; 42 : 272-82
6. Caballeria L, Auladell MA, Torán P, et al. Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study. BMC Gastroenterol 2008 ; 8 : 44-50
7. Sowers M F, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 2007 ; 92 : 895-901
8. Mayes J S, Watson G H. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004 ; 5 : 197-216
9. Zhang C, Rexrode K M, van Dam R M, Li T Y, Hu F B. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality. Sixteen years of follow-up in US women. Circulation 2008 ; 117 : 1658-67
10. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005 ; 42 : 987-1000
11. Dowman J K, Tomlinson J W, Newsome P N. Pathogenesis of nonalcoholic fatty liver disease. Q J Med 2010 ; 103 : 71-83
12. Hamguchi M, Kojima T, Ohbora A, Takeda Nm Fukui N, Kato T. Aging is a risk factor of non alcoholic fatty liver disease in premenopausal women. World J Gastroenterol 2012 ; 18 : 237-43
13. Gutierrez-Grobe Y, Ponciano-Rodriguez G, Ramos M H, Uribe M, Mendez-Sanchez N. Prevalence of non alcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogen. Ann Hepatol 2010 ; 9 : 402-9
14. NCEP Expert Panel on the detection, evaluation, and treatment of high blood pressure in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Adult Treatment Panel III (ATP III). JAMA 2001 ; 285 : 2444-9
15. Geloneze B, Repetto E M, Geloneze S R, Tambascia M A, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixture population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006 ; 72 : 219-20
16. Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med 2002 ; 21 : 1023-32
17. Adams L A, Lymp J F, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterol 2005 ; 129 : 113-21
18. Williams C D, Stengel J, Asike M I, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011 ; 140 : 124-31
19. Volzke H, Schwarz S, Baumeister SE, et al. Menopausal status and hepatic steatosis in a general female population. Gut 2007 ; 56 : 594-5
20. Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res 2007 ; 37 : 239-47
21. Tardivo AP, Nahas-Neto J, Nahas EAP, Maesta N, Rodrigues MH, Orsatti FL. Associations between healthy eating patterns and indicators of metabolic risk in postmenopausal women. Nutr J 2010 ; 9 : 64
22. Nahas EAP, Padoani NP, Nahas-Neto J, Orsatti FL, Tardivo AP, Dias R. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Climacteric 2009 ; 12 : 431-8
23. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome. Hepatology 2003 ; 37 : 917-23
24. McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006 ; 40 : S17-29
25. Petta S, Muratore C, Craxì A. Non-alcoholic fatty liver disease pathogenesis: The present and the future. Dig Liver Dis 2009 ; 41 : 615-25
26. Caballeri a L, Pera G, Rodriguez L, Auladell MA, Bernard J, Toran SC. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: infl uence of the diagnostic criteria used. Eur J Gastroenterol Hepatol 2012 ; 24 : 1007-11
27. Dowman J K, Tomlinson J W, Newsome J W. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011 ; 33 : 525-40
28. IBGE. POF (Pesquisa de Orç amentos Familiares) 2008- 2009. http://www.ibge.gov.br/home/presidencia/noticias/ accessed on September 26th, 2013
29. Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. Am J Roentgenol 2007 ; 189 : W320-3
30. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Clark JM. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011 ; 54 : 1082-90